Bridgewater Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$312K Buy
352
+12
+4% +$9.07K 0.02% 365
2026
Q2
$252K Buy
340
+21
+7% +$14.3K 0.01% 417
2026
Q1
$225K Sell
319
-3
-0.9% -$2.3K 0.01% 418
2025
Q4
$237K Buy
+322
New +$219K 0.02% 410

Other funds holding REGN

Bridgewater Advisors's REGN Position: Q3 2026 in Review

Bridgewater Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 3.5% in Q3 2026, buying an estimated $9.07K and bringing the position to 352 shares worth $312K. The position accounts for 0.02% of the portfolio, ranked #365.

Bridgewater Advisors first reported a position in REGN in Q4 2025 and has held it in 4 quarters since. 1,433 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Bridgewater Advisors held 352 shares of Regeneron Pharmaceuticals worth $312K as of Q3 2026.
  • Bridgewater Advisors bought 12 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $9.07K.
  • Regeneron Pharmaceuticals made up 0.02% of Bridgewater Advisors's portfolio in Q3 2026, its #365 holding.
  • Bridgewater Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 1,433 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Bridgewater Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.